Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke

NCT: NCT01855633 · RECRUITING

NCT IDNCT01855633
StatusRECRUITING
Start Date2013-04-26
Completion2040-12
SponsorDongtan Sacred Heart Hospital (OTHER)
First posted
Last updated

Brief Summary

Stroke is one of the major causes of death in the World. Many stroke survivors may suffer from long-term sequelae of stroke such as hemiplegia. The effects of rehabilitation therapy are limited. The development of new treatment strategies is essential. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive method to stimulate the focal area of the brain for restoring brain function. The aim of this study is to investigate the therapeutic effect of rTMS on the motor recovery in patients with hemiplegic stroke.

Frequently Asked Questions

What is Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke?

Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke is a clinical trial registered under NCT01855633. Current status: RECRUITING.

What is the status of NCT01855633?

The current status of NCT01855633 (Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke) is: RECRUITING.

When did Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke start?

Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke started on 2013-04-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.